Surgical Suture Market By Key Manufacturers, By Product Type - Absorbable Sutures (Natural Sutures and Synthetic Sutures) and Non-absorbable Sutures (Nylon Sutures, Polypropylene Sutures and Stainless Steel Sutures), By Application (General Surgery, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Other Surgeries), By End-Users (Hospitals, Specialty Clinics and Ambulatory Surgery Centers) and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 41486 | Jan 2019 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
The global Surgical Suture market is valued USD 5.1 Billion in 2017 and is projected is to exhibit 4.4% CAGR during the forecast period. The market is projected to be around USD 7.2 Billion by 2026. The market is driven by occurrence of medical disorders associated to peripheral vascular surgery, soft tissues, trauma, breast, skin, and hernias.

Surgical sutures is a medical device, which is used to hold body tissue together and aids to close a wound. These are usually called stitches, which includes the use of a needle with an attached length of thread. This medical device are used to close wound in numerous disease for instance such as diabetic ulcers, skin ulcers, pediatric cardiac surgery and neuropathic ulcers.
Surgical Suture Market Dynamics
Currently, the global surgical sutures market is driven by rising aging population, growing occurrence of chronic diseases, increasing healthcare expenditure, growing numeral of surgeries and burns and growing the number of hospitals and clinics. Also, the incessant surge in geriatric population and the increasing number of musculoskeletal diseases are also predictable to propel the global market during the forecast period.

Though, rising need for progressive wound closure materials, side effects from surgical sutures and lack of product innovations in the surgical sutures act as a key barrier for this industry.
Surgical Suture Market Insight
North America holds the major market share of the global surgical suture market owing to presence good healthcare regime in the region, wherein Asia Pacific region is expected to witness fastest growth rate owing to the economic option to cure the disease, growing elderly population and low disposable income in this region. Followed by North America, Europe is anticipated to capture second largest market share in the global surgical suture market owing developed healthcare infrastructure.
Surgical Suture Market Segmentation
The global surgical suture market is segmented into product type, application, end-user and region. On the basis of the product type the market is further bifurcated into absorbable sutures and non-absorbable sutures. These absorbable sutures is segmented into natural sutures and synthetic sutures. Similarly the non-absorbable sutures nylon sutures, polypropylene sutures, and stainless steel sutures. On the basis of application the global surgical suture market is segmented into nylon sutures, polypropylene sutures, and stainless steel sutures. On the basis of the end-user the market is segmented into hospitals, specialty clinics, and ambulatory surgery centers. Based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Surgical Suture Market Competitive Landscape
The players associated with the global surgical suture market are ConMed Corp., Teleflex Inc., Zimmer Biomet Holdings Inc., Integra LifeSciences Corp., Acelity L.P. Inc., Medtronic Plc, B. Braun Melsungen AG, Johnson & Johnson, Smith & Nephew Plc, and Boston Scientific Corp.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Surgical Suture Market, By Product Type
5.1. Surgical Suture Market, by Product Type, 2018-2026
5.1.1. Absorbable Sutures
5.1.1.1. Natural Sutures
5.1.1.2. Synthetic Sutures
5.1.2. Non-Absorbable Sutures
5.1.2.1. Nylon Sutures
5.1.2.2. Polypropylene Sutures
5.1.2.3. Stainless Steel Sutures
Chapter 6. Surgical Suture Market, By Application
6.1. Surgical Suture Market, by Application, 2018-2026
6.1.1. General Surgery
6.1.2. Gynecological Surgeries
6.1.3. Cardiovascular Surgeries
6.1.4. Orthopedic Surgeries
6.1.5. Other Surgeries
Chapter 7. Surgical Suture Market, By End-User
7.1. Surgical Suture Market, by End-user, 2018-2026
7.2. Hospitals
7.3. Specialty Clinics
7.4. Ambulatory Surgery Centers
Chapter 8. Surgical Suture Market, By Region
8.1. Surgical Suture Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles
10.1. ConMed Corp.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Teleflex Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Zimmer Biomet Holdings Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Integra LifeSciences Corp.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Medtronic Plc
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. B. Braun Melsungen AG
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Smith & Nephew Plc
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Boston Scientific Corp.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Acelity L.P. Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
ConMed Corp.
Teleflex Inc.
Zimmer Biomet Holdings Inc.
Integra LifeSciences Corp.
Acelity L.P. Inc.
Medtronic Plc
B. Braun Melsungen AG
Johnson & Johnson
Smith & Nephew Plc
Boston Scientific Corp

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404